1. Shikimic acid was shown to be a precursor of vitamin K2 (MK-8) in Escherichia coli. 2. The benzene ring of the naphthaquinone arises from shikimic acid. 3. The methyl group of methionine is incorporated into vitamin K2. 4 . A scheme relating the biosynthesis of vitamin K2 and ubiquinone to the general pathway of aromatic biosynthesis is proposed.
Virtually nothing is known about the route of biosynthesis of the naphthaquinone part of the molecule of vitamin K. It is thought that, in moulds and higher plants, naphthaquinone synthesis in general may take place by the acetate pathway (for references see Geissman, 1963) . Gatenbeck & Bentley (1965) , studying biosynthesis of the naphthaquinone, javanicin, produced by Fusarium javanicum, have come to the same conclusion.
Lederer and his colleagues (Lederer, 1964; Azerad, Bleiler-Hill & Lederer, 1965) Scholes & King, 1965) with whole cells and cell-free preparations from Mycobacterium phlei.
The following experiments show that shikimate is probably a precursor of vitamin K2 in Escherichia coli and Aerobacter aerogenes and an attempt has been made to relate this finding to the general scheme of aromatic biosynthesis. A preliminary account of part of this work has been published (Cox & Gibson, 1964) .
EXPERIMENTAL
Organisms. The organisms used were a wild-type strain of B. coli (strain 518), an aromatic auxotroph of A. aerogenes (strain 170-44) unable to convert 3-enolpyruvoylshikimate 5-phosphate into chorismate and a methionine auxotroph (strain 5/17) derived from E. coli 518 after ultraviolet irradiation and penicillin selection. A. aerogenes strain 170-44 has been described previously . The position ofthe metabolic block in the methionine auxotroph was not determined. The organisms were kept on meat-infusion-agar slopes and subcultured monthly.
Cultivation of cells for extraction of quinones. Cells were usually grown at 370 as 11. batch cultures shaken in 21. flasks. The minimal medium used was that described by Vogel & Bonner (1956 Bioch. 1966, 100 acetylated, ozonized and oxidized by using the method developed for the degradation of ubiquinones by Bentley, Ramsey, Springer, Dialameh & Olson (1965 McCorquodale et al. (1939) . (b) 1,4-Diacetoxy-2-methylnaphthalene-3-acetic acid to phthalic anhydride. The method was based on that described by Binkley, McKee, Thayer & Doisy (1940) for the degradation of the diacetate of dihydrovitamin K2 (MK-6). 1,4-Diacetoxy-2-methylnaphthalene-3-acetic acid (100mg.) recrystallized to constant specific activity was added to a solution of 3.5g. of KMnO4 in 50ml. of acetone and refluxed for 5hr. The MnO2 was cleared with 802, 30ml. of water added and the solution acidified with HCI. After evaporation of the acetone the aqueous solution was extracted five times with equal volumes of ether. The pooled ether extracts were evaporated to dryness under reduced pressure and the residue was taken up in about 50ml. of ether. The volume of the ether solution was reduced to about 2ml. and the phthalic acid precipitated with light petroleum.
The product was converted into phthalic anhydride and purified by subliming twice at 180°and atmospheric pressure. To purify to constant specific activity the phthalic anhydride was repeatedly crystallized from ether-light petroleum and resublimed. The final yield was 17mg.
(about 30%). The identity of the phthalic anhydride was checked by m.p. and mixed m.p. (130°).
Identification of vitamin K2 (MK-8) and ubiquinone-8 from E. coli. The vitamin K2 from E. coli was identified by examination of the u.v. and i.r. spectra (Isler & Wiss, 1959) . The presence of eight unsaturated isoprene units (Bishop, Pandya & King, 1962) was confirmed by mass spectrometry, which gave a mass of 716.
The identity of ubiquinone was checked by u.v. and i.r.
spectra (Langemann & Isler, 1965 ) and a mass measurement gave 726, thus confirming the presence of ubiquinone-8 in E. coli (Lester & Crane, 1959) . Mass spectrometry of the ubiquinone isolated from E. coli K 12 showed a peak indicating a small proportion of ubiquinone-9. Isotope counting techniques. Radioactivity on thin-layer chromatograms was measured with a Nuclear-Chicago Actigraph with an attachment for thin-layer plates. For counting of solid samples aluminium planchets of approx. 7cm.2 area were used in a Nuclear-Chicago automatic gasflow counting system. The sample was plated by adding a solution to the planchet and 30mg. of silica gel G was added to aid plating.
The resultant slurry was spread uniformly over the surface of the planchet by a finely drawn-out glass rod and then dried gently.
In all experiments, the time was taken for at least 5120 counts, which gave a reliable error of 2-3%. A background count and a standard count were included with each set.
A compound was regarded as being at constant specific activity if, after further purification, the value obtained for the activity was within 4% of the value of the starting material. Where the specific activities of two compounds were directly compared the sample weights were sufficiently similar to make errors due to self-absorption less than 1%.
RESULTS
Demonstration of the incorporation of 8hikimic acid into vitamin K. Preliminary experiments on the incorporation of shikimate were carried out by growing the cells in the presence of [14C]shikimate. The cells were harvested, extracted as described above and the extracts chromatographed on thinlayer plates. Vitamin K and ubiquinone appeared as yellow bands and the plates were scanned for Distance from origin (cm.) Fig. 1 Compari8on of the amount of [14C]8hikimic acid incorporated into vitamin K and ubiquinone. Cells of wild-type E. coli were grown in minimal medium plus phenylalanine, tyrosine and tryptophan (final concn. of each O-1 mm) as described in the Experimental section, with the addition of [G-14C]-shikimic acid (final concn. 0-1 mm; specific activity 750 000 counts/min./m-mole). After growth the cells were harvested, and the quinones were extracted, chromatographed twice and then crystallized twice from methanol before determination of specific activity. The comnpounds were then recrystallized to constant specific activity. The values at constant specific activity were: vitamin K2 (MK-8), 80000 counts/min./m-mole; ubiquinone-8, 95000 counts/min./m-mole.
Incorporation of 8hikimic acid into the naphthaquinone of vitamin K2. To the vitamin K2 obtained as in the above experiment, vitamin K, was added as carrier (for details see the Experimental section) and the vitamin K mixture then reductively acetylated, ozonized and oxidized to 1,4-diacetoxy-2-methylnaphthalene-3-acetic acid, which was in turn further oxidized to phthalic anhydride as Table 2 . Some radioactivity is found in the phthalic anhydride and the significance of this result is discussed below.
The methionine auxotroph of E. coli (strain 5/17) was grown in the glucose-citrate-mineral salts medium to which had been added [Me-14C]-methionine. The vitamin K2 from the cells was isolated, carrier vitamin K1 added and the degradation carried out giving the results summarized in Table 2 . The radioactivity is retained in the 1,4-diacetoxy-2-methylnaphthalene-3-acetic acid. Lederer (1964) and Azerad et al. (1965) but proof is still lacking that this methyl group is the source ofthe 2-methyl group ofthe naphthaquinone.
DISCUSSION
The observation that shikimic acid is incorporated into ubiquinone and vitamin K raises the question where the biosynthetic routes for these compounds diverge from the pathways of biosynthesis of aromatic compounds. Ubiquinone has previously been suggested to arise from 4-hydroxybenzoate (Parson & Rudney, 1964) , which in turn is formed from chorismate growth by 3,4-dihydroxybenzaldehyde has only beeri described for aromatic auxotrophs with metabolic lesions before chorismate, suggesting that prephenate is probably not a precursor. Thus, though the possibility of a pathway through prephenate cannot be excluded, it is tentatively suggested that the pathway is as shown in Scheme 1.
3,4-Dihydroxybenzaldehyde was tested as a possible precursor of vitamin K because of the observation by Davis (1952a,b) that, under certain conditions, some multiple aromatic auxotrophs required an extra growth factor (sixth factor). This sixth-factor requirement could be satifised by 3,4-dihydroxybenzaldehyde or related compounds such as adrenaline. There is little reason to suppose that 3,4-dihydroxybenzaldehyde itself is on the direct route of biosynthesis of vitamin K. Related compounds such as 3,4-dihydroxybenzoate did not interfere with the incorporation of [14C]shikimate but whether such compounds can enter the intact cell is not known. It might be noted that compounds such as 2,3-dihydroxybenzoate and 3,4-dihydroxybenzoate are excreted by various aromatic auxotrophs (Pittard, Gibson & Doy, 1961 . Apart from the possible roles of 4-hydroxybenzoate and 3,4-dihydroxybenzaldehyde, nothing is known of the intermediates involved in the biosynthesis of vitamin K and ubiquinone from chorismate.
was supported by grants from the Australian National Health and Medical Research 
